Ameriprise Financial Inc Prothena Corp Public LTD CO Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.31 - $52.32 $87,140 - $141,107	2,697 Added 24.38%	13,760 $500,000
Q3 2023 Nov 14, 2023	SELL	$47.3 - $70.6 $40,346 - $60,221	-853 Reduced 7.16%	11,063 $533,000
Q2 2023 Aug 14, 2023	SELL	$48.26 - $78.59 $4,632 - $7,544	-96 Reduced 0.8%	11,916 $813,000
Q1 2023 May 15, 2023	SELL	$46.97 - $58.27 $571,530 - $709,029	-12,168 Reduced 50.32%	12,012 $582,000
Q4 2022 Feb 14, 2023	SELL	$52.05 - $65.0 $528,463 - $659,945	-10,153 Reduced 29.57%	24,180 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$25.16 - $60.63 $229,559 - $553,188	9,124 Added 36.19%	34,333 $2.08 Million
Q2 2022 Aug 15, 2022	SELL	$22.73 - $39.98 $69,258 - $121,819	-3,047 Reduced 10.78%	25,209 $685,000
Q1 2022 May 16, 2022	BUY	$30.27 - $49.22 $418,815 - $681,007	13,836 Added 95.95%	28,256 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$42.11 - $73.26 $223,056 - $388,058	5,297 Added 58.06%	14,420 $712,000
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $439,728 - $719,713	9,123 New	9,123 $650,000
Q2 2021 Aug 16, 2021	SELL	$21.63 - $57.65 $384,840 - $1.03 Million	-17,792 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$11.0 - $28.24 $256,047 - $657,342	-23,277 Reduced 56.68%	17,792 $447,000
Q4 2020 Feb 12, 2021	SELL	$10.12 - $13.94 $89,147 - $122,797	-8,809 Reduced 17.66%	41,069 $493,000
Q3 2020 Nov 16, 2020	BUY	$9.93 - $13.47 $29,869 - $40,517	3,008 Added 6.42%	49,878 $499,000
Q2 2020 Aug 14, 2020	SELL	$9.56 - $12.51 $1,099 - $1,438	-115 Reduced 0.24%	46,870 $490,000
Q1 2020 May 15, 2020	BUY	$7.54 - $15.77 $550 - $1,151	73 Added 0.16%	46,985 $503,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $17.01 $59,114 - $134,430	7,903 Added 20.26%	46,912 $743,000
Q3 2019 Nov 14, 2019	BUY	$6.89 - $10.45 $46,734 - $70,882	6,783 Added 21.05%	39,009 $306,000
Q2 2019 Aug 14, 2019	BUY	$8.85 - $12.49 $34,426 - $48,586	3,890 Added 13.73%	32,226 $341,000
Q1 2019 May 15, 2019	BUY	$10.32 - $14.49 $111,755 - $156,912	10,829 Added 61.86%	28,336 $343,000
Q4 2018 Feb 14, 2019	BUY	$8.73 - $13.74 $152,713 - $240,353	17,493 Added 124950.0%	17,507 $180,000
Q3 2018 Nov 14, 2018	BUY	$12.7 - $15.79 $177 - $221	14 New	14 $188,000
Q2 2018 Aug 14, 2018	SELL	$10.99 - $44.21 $98,118 - $394,706	-8,928 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$27.95 - $45.04 $249,537 - $402,117	8,928 New	8,928 $328,000

Others Institutions Holding PRTA

# of Institutions

186

Shares Held

42.8M

Call Options Held

162K

Put Options Held

102K

Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$179 Million
8.41% of portfolio
Wellington Management Group LLP Boston, MA

4.18M
Shares

$64.7 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.86M
Shares

$59.7 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.82M
Shares

$59.2 Million
0.01% of portfolio
Palo Alto Investors LP Palo Alto, CA

1.74M
Shares

$26.9 Million
4.0% of portfolio

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $726M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account